Lincoln Pharma looks like ready to trade higher. Its financials are improving and recently it has launched extended release oral suspension drugs which is cough syrup. It is a dividend paying company.
Promoters stake has increased by 3.88%.

Improved Credit rating in Nov, 2014. A3+.

PE=12.42.
PB=1.85.

CMP: Rs 127.